M. Constantine Samaan

Dr. M. Constantine Samaan


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2023 in JAMA Network Open
Verified
Journal Article
Closed access
PDF file
MCMilena Cioana
Milena Cioana
JDJiawen Deng
Jiawen Deng
ANAjantha Nadarajah
Ajantha Nadarajah
MHMaggie Hou
Maggie Hou
YQYuan Qiu
Yuan Qiu
MSM. Constantine Samaan
M. Constantine Samaan
Importance: Type 2 diabetes (T2D) is increasing globally. Diabetic retinopathy (DR) is a leading cause of blindness in adults with T2D; however, the global burden of DR in pediatric T2D is unknown. This knowledge can inform retinopathy screening and treatments to preserve vision in this population.Objective: To estimate the global prevalence of DR in pediatric T2D.Data Sources: MEDLINE, Embase, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), the Cochrane Library, the Web of Science, and the gray literature (ie, literature containing information that is not available through traditional publishing and distribution channels) were searched for relevant records from the date of database inception to April 4, 2021, with updated searches conducted on May 17, 2022. Searches were limited to human studies. No language restrictions were applied. Search terms included diabetic retinopathy; diabetes mellitus, type 2; prevalence studies; and child, adolescent, teenage, youth, and pediatric.Study Selection: Three teams, each with 2 reviewers, independently screened for observational studies with 10 or more participants that reported the prevalence of DR. Among 1989 screened articles, 27 studies met the inclusion criteria for the pooled analysis.Data Extraction and Synthesis: This systematic review and meta-analysis followed the Meta-analysis of Observational Studies in Epidemiology (MOOSE) and the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guidelines for systematic reviews and meta-analyses. Two independent reviewers performed the risk of bias and level of evidence analyses. The results were pooled using a random-effects model, and heterogeneity was reported using χ2 and I2 statistics.Main Outcomes and Measures: The main outcome was the estimated pooled global prevalence of DR in pediatric T2D. Other outcomes included DR severity and current DR assessment methods. The association of diabetes duration, sex, race, age, and obesity with DR prevalence was also assessed.Results: Among the 27 studies included in the pooled analysis (5924 unique patients; age range at T2D diagnosis, 6.5-21.0 years), the global prevalence of DR in pediatric T2D was 6.99% (95% CI, 3.75%-11.00%; I2 = 95%; 615 patients). Fundoscopy was less sensitive than 7-field stereoscopic fundus photography in detecting retinopathy (0.47% [95% CI, 0%-3.30%; I2 = 0%] vs 13.55% [95% CI, 5.43%-24.29%; I2 = 92%]). The prevalence of DR increased over time and was 1.11% (95% CI, 0.04%-3.06%; I2 = 5%) at less than 2.5 years after T2D diagnosis, 9.04% (95% CI, 2.24%-19.55%; I2 = 88%) at 2.5 to 5.0 years after T2D diagnosis, and 28.14% (95% CI, 12.84%-46.45%; I2 = 96%) at more than 5 years after T2D diagnosis. The prevalence of DR increased with age, and no differences were noted based on sex, race, or obesity. Heterogeneity was high among studies.Conclusions and Relevance: In this study, DR prevalence in pediatric T2D increased significantly at more than 5 years after diagnosis. These findings suggest that retinal microvasculature is an early target of T2D in children and adolescents, and annual screening with fundus photography beginning at diagnosis offers the best assessment method for early detection of DR in pediatric patients.

1 December 2022 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
MCMilena Cioana
Milena Cioana
JDJiawen Deng
Jiawen Deng
ANAjantha Nadarajah
Ajantha Nadarajah
MHMaggie Hou
Maggie Hou
YQYuan Qiu
Yuan Qiu
MSM. Constantine Samaan
M. Constantine Samaan
In the past few decades, type 2 diabetes (T2D) in children and adolescents has emerged in conjunction with increasing pediatric obesity rates globally.1-8 Children and youth living with obesity also have a higher risk of developing T2D as adults when compared with children with reference range weight, which may contribute to increased cardiovascular risk.9

15 February 2022 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
MCMilena Cioana
Milena Cioana
JDJiawen Deng
Jiawen Deng
ANAjantha Nadarajah
Ajantha Nadarajah
MHMaggie Hou
Maggie Hou
YQYuan Qiu
Yuan Qiu
MSM. Constantine Samaan
M. Constantine Samaan
Over the past 3 decades, type 2 diabetes (T2D) has made the transition from being an adult disease to being a pediatric disorder.1-8 T2D in youth is an aggressive disease with multiple associated comorbidities and poor response to current therapies; it is also associated with higher morbidity and mortality rates than adult-onset T2D.9-11

1 April 2021 in JAMA Network Open
Verified
Journal Article
Closed access
PDF file
MCMilena Cioana
Milena Cioana
JDJiawen Deng
Jiawen Deng
MHMaggie Hou
Maggie Hou
ANAjantha Nadarajah
Ajantha Nadarajah
YQYuan Qiu
Yuan Qiu
MSM. Constantine Samaan
M. Constantine Samaan
The global increase in obesity has driven the emergence of type 2 diabetes in children.1,2 Pediatric type 2 diabetes is an aggressive disease with greater risk of end-organ damage and comorbidities than pediatric type 1 diabetes or adult-onset type 2 diabetes.1-5 The kidneys are notable early targets of type 2 diabetes–associated organ damage, and diabetes-related nephropathy commonly manifests as hypertension and albuminuria.6-8 If untreated, hypertension is associated with cardiovascular anomalies, including increased carotid intima-media thickness and left ventricular hypertrophy.9,10 These subclinical adverse outcomes are known risk factors for future cardiovascular disease and mortality.9,10 Similarly, microalbuminuria is the first sign of diabetes-related nephropathy and can progress to chronic kidney disease and end-stage kidney disease if untreated.11

11 October 2017 in Clinical Obesity
Verified
Journal Article
Open access
PDF file
KWK‐W. Wang
K‐W. Wang
Adam FlemingAdam Fleming
Adam Fleming
DJD. L. Johnston
D. L. Johnston
SZS. M. Zelcer
S. M. Zelcer
SRShahrad Rod Rassekh
Shahrad Rod Rassekh
MSM. Constantine Samaan
M. Constantine Samaan
Summary: Survivors of childhood brain tumours (SCBT) have increased cardiometabolic risks, but the determinants of these risks are unclear. This systematic review aims to compare the prevalence of overweight and obesity as well as adiposity measures between SCBT and non‐cancer controls. The PubMed, EMBASE, MEDLINE, CINAHL and the Cochrane Library databases were searched. The primary outcomes were the prevalence of overweight and obesity based on body mass index. The secondary outcomes were adiposity measures including percent fat mass, waist‐to‐hip and waist‐to‐height ratios. Forty‐one studies were included in the meta‐analysis. The prevalence of overweight and obesity combined was similar between overall SCBT, SCBT excluding craniopharyngioma and non‐cancer controls (42.6%, 95% CI 30.1–55.1 vs. 31.7%, 95% CI 20.4–43.0 vs. 40.4%, 95% CI 34.0–46.8). We also found that SCBT have higher percent fat mass (mean difference 4.1%, 95% CI 2.0–6.1), waist‐to‐hip ratio (mean difference 0.07, 95% CI 0.02–0.13) and waist‐to‐height ratio (mean difference 0.06, 95% CI 0.01–0.10) than non‐cancer controls. We conclude that SCBT have similar overweight and obesity distribution but higher adiposity than non‐cancer controls. More studies were needed to explore the determinants of adiposity and its contribution to cardiometabolic outcomes in SCBT.

20 May 2014 in Physiological Reports
Verified
Journal Article
Open access
PDF file
MSM. Constantine Samaan
M. Constantine Samaan
KMKatarina Marcinko
Katarina Marcinko
SSSarah Sikkema
Sarah Sikkema
MFMorgan D. Fullerton
Morgan D. Fullerton
TZTahereh Ziafazeli
Tahereh Ziafazeli
GSGregory R. Steinberg
Gregory R. Steinberg
Obesity is associated with chronic low‐grade inflammation that involves infiltration of macrophages into metabolic organs such as skeletal muscle. Exercise enhances skeletal muscle insulin sensitivity independently of weight loss; but its role in regulating muscle inflammation is not fully understood. We hypothesized that exercise training would inhibit skeletal muscle inflammation and alter macrophage infiltration into muscle independently of weight loss. Wild type C57BL/6 male mice were fed a chow diet or a high‐fat diet (HFD, 45% calories fat) for 6 weeks. Then, mice maintained on the HFD either remained sedentary (HFD Sed) or exercised (HFD Ex) on a treadmill for another 6 weeks. The exercise training protocol involved conducting intervals of 2 min in duration followed by 2 min of rest for 60 min thrice weekly. Chow‐fed control mice remained sedentary for the entire 12 weeks. Muscle cytokine and macrophage gene expression analysis were conducted using qRT‐PCR, and muscle macrophage content was also measured using immunohistochemistry. Muscle cytokine protein content was quantified using a cytokine array. The HFD increased adiposity and weight gain compared to chow‐fed controls. HFD Sed and HFD Ex mice had similar body mass as well as total and visceral adiposity. However, despite similar adiposity, exercise reduced inflammation and muscle macrophage infiltration. We conclude that Endurance exercise training modulates the immune‐metabolic crosstalk in obesity independently of weight loss, and may have potential benefits in reducing obesity‐related muscle inflammation.